PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of frontmicrobioLink to Publisher's site
 
Front Microbiol. 2017; 8: 334.
Published online 2017 March 7. doi:  10.3389/fmicb.2017.00334
PMCID: PMC5339647

Contribution of Ultra Deep Sequencing in the Clinical Diagnosis of a New Fungal Pathogen Species: Basidiobolus meristosporus

Abstract

Some cases of fungal infection remained undiagnosed, especially when the pathogens are uncommon, require specific conditions for in vitro growth, or when several microbial species are present in the specimen. Ultra-Deep Sequencing (UDS) could be considered as a precise tool in the identification of involved pathogens in order to upgrade patient treatment. In this study, we report the implementation of UDS technology in medical laboratory during the follow-up of an atypical fungal infection case. Thanks to UDS technology, we document the first case of gastro-intestinal basidiobolomycosis (GIB) due to Basidiobolus meristosporus. The diagnosis was suspected after histopathological examination but conventional microbiological methods failed to supply proof. The final diagnosis was made by means of an original approach based on UDS. DNA was extracted from the embedded colon biopsy obtained after hemicolectomy, and a fragment encompassing the internal transcribed spacer (ITS) rDNA region was PCR-amplified. An Amplicon library was then prepared using Genome Sequencer Junior Titanium Kits (Roche/454 Life Sciences) and the library was pyrosequenced on a GS Junior (Roche/454 Life Sciences). Using this method, 2,247 sequences with more than 100 bases were generated and used for UDS analysis. B. meristosporus represented 80% of the sequences, with an average homology of 98.8%. A phylogenetic tree with Basidiobolus reference sequences confirmed the presence of B. meristosporus (bootstrap value of 99%).

Conclusion : UDS-based diagnostic approaches are ready to integrate conventional diagnostic testing to improve documentation of infectious disease and the therapeutic management of patients.

Keywords: Ultra-Deep Sequencing, fungal infection, gastro-intestinal basidiobolomycosis, Basidiobolus meristosporus, ITS amplicons

Introduction

Fungal infections can be challenging when the pathogen is uncommon, requires specific in vitro growth conditions, or is part of a multimicrobial community. Therefore, some cases of fungal or other infectious diseases remain undiagnosed despite extensive clinical laboratory investigations. In such conditions, Ultra Deep Sequencing (UDS) appears to be a good compromise to improve laboratory identification of involved pathogens and subsequently adapt their therapeutic treatment (Wilson et al., 2014).

Our aim was to show how diagnosis of infection in a polymicrobial sample could be achieved when conventional microbiological methods fail. We report the implementation of UDS technology in medical laboratory work during the follow-up of an unusual fungal infection case and with which the first diagnosis of gastrointestinal basidiobolomycosis (GIB) caused by Basidiobolus meristosporus was reached.

History

A 41-year-old female, native and living in Cameroon without any past history of travel to other countries, was presented with abdominal pain, which started 2 months prior to her hospital admission. The patient was HIV-positive (330 CD4/mm3), on HAART treatment, and her disease was well controlled (undetectable HIV RNA load). An abdominal CT-scan revealed a large mass in the right lower abdomen, which involved the ascending colon, the terminal ileum and the bladder. An emergency laparotomy showed that the mass was highly inflammatory and had pseudotumoral appearance with a fistula. On that occasion, the patient underwent a right hemicolectomy, Hartmann procedure, bladder suture, and Miculicz drainage. Histopathological examination and conventional microbial cultures of the surgical specimen were performed. The main results of the histopathological examination, upon using Periodic acid-Schiff staining, showed large hyphae surrounded by a thick eosinophilic material (Splendore-Hoeppli phenomenon) (Figure (Figure1A).1A). A presumptive diagnosis of fungal infection possibly by Basidiobolus sp. was made though no positive culture of this fungus was obtained. Basidiobolus spp. cannot be isolated if sample is stored at 4°C or if Sabouraud agar media contain antibiotics (Al-Naemi et al., 2015; Geramizadeh et al., 2015; Shaikh et al., 2016). Futhermore, hyphae of Basidiobolus spp. may be easily damaged during tissue homogenization processing. The patient received post-op liposomal amphotericin B (5 mg/kg/day) and fluconazole (400 mg/day) for 10 days followed by oral and IV itraconazole (200 mg × 2/day), but she died 3 months later after several episodes of septic shock.

Figure 1
(A) Colon biopsy stained with Periodic acid-Schiff stain showing several hyphal structures (black arrows) surrounded by eosinophilic-rich infiltrate called Splendore-Hoeppli phenomenon (magnification × 400). (B) ITS2 Sanger electropherogram showing ...

Methodology of the diagnosis

This study was carried out in compliance with the Helsinki declaration. A written consent form was obtained from the family for publication.

After the surgery, a DNA extraction from a formalin-fixed, paraffin-embedded tissue biopsy, obtained from the excised colon, was made using a BioRobot EZ1 (Qiagen), and followed by amplification and Sanger sequencing of the internal transcribed spacer (ITS) regions of the fungal rDNA (White et al., 1990). The results of ITS sequencing remained inconclusive because of superposition of several electropherograms, suggesting the coexistence of several fungal species (Figure (Figure1B).1B). Thus, we decided to use UDS to identify the culprit fungal pathogen within this polymicrobial sample, and for such analysis the ITS2 region was PCR-amplified. An Amplicon library was then prepared using GS Junior Titanium Kits (Roche/454 Life Sciences) and the library was pyrosequenced on a Genome Sequencer Junior (Roche/454 Life Sciences). The generated data were analyzed with PyroMIC (protected software, IDDN FR.001.400018.000.S.P.2014.000.31230) which contains a cleaned fungal database created from ITS NCBI fungal sequences. Ultimately, only sequences of >100 bp, with ≥98% homology, and 0.0 e-value were considered for species identification. Haplotypes of sequences of interest were done by means of CD-HIT software (Li and Godzik, 2006; Ghannoum et al., 2010; Findley et al., 2013). A nucleotide alignment, by CLUSTAL X, was used to build a dendrogram using the Neighbor Joining, Kimura 2 parameter method, 1,000 bootstrap, with the MEGA6 software (Tamura et al., 2013).

As for the UDS method, 2,247 sequences (matching quality criteria) were used for analysis. For identification at the species level, the software considered 1,832 sequences with an average length of 440 bp. Overall, four different species were identified, of which B. meristosporus represented 80% (1,466/1,832) of the sequences, Malassezia globosa 7.2% (1,32/1,832), Malassezia restricta 6.8% (124/1,832), and Candida zeylanoides 6% (110/1,832), with an average homology of 98.8, 98.7, 99.0, and 99.0% respectively. Among the B. meristosporus sequences, four haplotypes were found and considered as representative sequences (NCBI Accession number: KM246888, KM246889, KM246890, KM246892) to construct a Neighbor Joining tree with all Basidiobolus spp. references that are available on NCBI. This tree showed a clusterization of our sequences with the two reference sequences of B. meristosporus (ATCC 14450 and isolate BCU1), and the bootstrap value was 99% (Figure (Figure1C).1C). Eventually, this approach enabled us to identify B. meristosporus as the causative pathogen of the GIB in this patient.

Discussion

We describe here the first human diagnosis of GIB due to B. meristosporus and the capacity of UDS-based diagnostic approach to detect fungal pathogen in a polymicrobial sample. As a result of the increase of immunocompromised patients and the emergence of new fungal pathogens, laboratories are facing diagnostic challenges to identify rare pathogens or pathogens implicated in polymicrobial samples (Irinyi et al., 2015). Basically, when a presumptive diagnosis of an infection is provoked, early detection and identification of the etiologic agent permits the initiation of appropriate antifungal therapy to reduce morbidity. When culture is possible, the fungal identification is made by morphological and biochemical methods, which are time-consuming and require trained lab personnel. Alternatively, molecular methods such as DNA barcoding, on isolated colonies, offer a practical approach for species identification (Irinyi et al., 2015). In culture negative cases, sequencing of a PCR product from tissue could be performed as an alternative means of diagnosis (El-Shabrawi et al., 2011). However, the presence of several coexisting species may hamper sequence reading.

In this context, the UDS has been integrated in the diagnostic process to identify such unusual fungal within the polymicrobial sample. GIB is a very rare emergent fungal infection caused by Basidiobolus spp. Although several species of Basidiobolus have been described in the literature (Gryganskyi et al., 2012), Basidiobolus ranarum was the only one reported in human gastrointestinal cases (Lyon et al., 2001). Nevertheless, in the few published cases, the diagnosis was based on histopathology examination and rarely on tissue culture or serodiagnosis. Indeed, in the review of the 44 cases of GIB published by Vikram et al., Basidiobolus spp. was isolated in culture from only of 24 patients for which a sample was available. In this review, the specific serum antibodies to B. ranarum were detected in only 8 (50%) of the 16 patients who underwent testing (Vikram et al., 2012). Currently molecular identification is the only method that gives a better species identification and since 2012, the Basidiobolus clade has included six distinct species which are closely related to each other (Gryganskyi et al., 2012). Accordingly, we can suppose that some reports on infections documented as B. ranarum-induced might be due to other species.

In the presented case, the histopathology result suggested Basidiobolus sp. but conventional diagnostics by culture or molecular approaches failed to identify the B. meristosporus, which was detected thanks to UDS. Only the detection of fungi by UDS approach would have provided conclusive information to give an adapted treatment. Furthermore, the sensitivity of the UDS methodology enabled the identification of additional yeast species (C. zeylanoides, M. globosa, and M. restricta), which were considered as either potentially implicated in the pathology or as sample contaminants (skin or gut biota) (Gouba et al., 2013). In brief, despite the availability of several conventional microbiological diagnostics, it will be interesting to use UDS with targeted approach for the polymicrobial samples diagnosis in some particular cases: (i) when the clinical presentation is atypical or when the patient is immunocompromised or comes from tropical countries, (ii) when the culture remain sterile despite positive histopathology or positive direct examination; (iii) for pathogens uncultivable or after the beginning of treatment (iv) to confirm the presence of pathogens requiring specific treatment or when the treatment incurs serious secondary effects (benefit-risk).

Moreover, free software versions are available to help interpret metagenomics data and the cost could be drastically decreased in the future with the development of UDS sharing platform. We believe that this approach is ready to integrate conventional diagnostic investigations to improve documentation of infectious disease and the therapeutic management of patients.

Author contributions

Conceptualization: FB, ES, and CR. Methodology: FB, ES, CR, and JMP. Software: ES and CR. Validation: FB and ES. Formal analysis: FB, ES, and CR. Investigation: FB. Resources: RM, JC, FF, and MD. Writing (original draft preparation): FB, ES, CR, and JMP. Supervision: FB.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank Dr Suhad Assad for her critical linguistic reviewing.

References

  • Al-Naemi A. Q., Khan L. A., Al-Naemi I., Amin K., Athlawy Y. A., Awad A., et al. . (2015). A case report of gastrointestinal basidiobolomycosis treated with voriconazole: a rare emerging entity. Medicine (Baltimore). 94:e1430. 10.1097/MD.0000000000001430 [PMC free article] [PubMed] [Cross Ref]
  • El-Shabrawi M. H. F., Kamal N. M., Jouini R., Al-Harbi A., Voigt K., Al-Malki T. (2011). Gastrointestinal basidiobolomycosis: an emerging fungal infection causing bowel perforation in a child. J. Med. Microbiol. 60, 1395–1402. 10.1099/jmm.0.028613-0 [PubMed] [Cross Ref]
  • Findley K., Oh J., Yang J., Conlan S., Deming C., Meyer J. A., et al. . (2013). Topographic diversity of fungal and bacterial communities in human skin. Nature 498, 367–370. 10.1038/nature12171 [PMC free article] [PubMed] [Cross Ref]
  • Geramizadeh B., Heidari M., Shekarkhar G. (2015). Gastrointestinal basidiobolomycosis, a rare and under-diagnosed fungal infection in immunocompetent hosts: A Review Article. Iran J. Med. Sci. 40, 90–97. [PMC free article] [PubMed]
  • Ghannoum M. A., Jurevic R. J., Mukherjee P. K., Cui F., Sikaroodi M., Naqvi A., et al. . (2010). Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 6:e1000713. 10.1371/journal.ppat.1000713 [PMC free article] [PubMed] [Cross Ref]
  • Gouba N., Raoult D., Drancourt M. (2013). Plant and fungal diversity in gut microbiota as revealed by molecular and culture investigations. PLoS ONE 8:e59474. 10.1371/journal.pone.0059474 [PMC free article] [PubMed] [Cross Ref]
  • Gryganskyi A. P., Humber R. A., Smith M. E., Miadlikowska J., Miadlikovska J., Wu S., et al. . (2012). Molecular phylogeny of the Entomophthoromycota. Mol. Phylogenet. Evol. 65, 682–694. 10.1016/j.ympev.2012.07.026 [PubMed] [Cross Ref]
  • Irinyi L., Serena C., Garcia-Hermoso D., Arabatzis M., Desnos-Ollivier M., Vu D., et al. . (2015). International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database–the quality controlled standard tool for routine identification of human and animal pathogenic fungi. Med. Mycol. 53, 313–337. 10.1093/mmy/myv008 [PubMed] [Cross Ref]
  • Li W., Godzik A. (2006). Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 22, 1658–1659. 10.1093/bioinformatics/btl158 [PubMed] [Cross Ref]
  • Lyon G. M., Smilack J. D., Komatsu K. K., Pasha T. M., Leighton J. A., Guarner J., et al. . (2001). Gastrointestinal basidiobolomycosis in Arizona: clinical and epidemiological characteristics and review of the literature. Clin. Infect. Dis. 32, 1448–1455. 10.1086/320161 [PubMed] [Cross Ref]
  • Shaikh N., Hussain K. A., Petraitiene R., Schuetz A. N., Walsh T. J. (2016). Entomophthoramycosis: a neglected tropical mycosis. Clin. Microbiol. Infect. 22, 688–694. 10.1016/j.cmi.2016.04.005 [PubMed] [Cross Ref]
  • Tamura K., Stecher G., Peterson D., Filipski A., Kumar S. (2013). MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol. Biol. Evol. 30, 2725–2729. 10.1093/molbev/mst197 [PMC free article] [PubMed] [Cross Ref]
  • Vikram H. R., Smilack J. D., Leighton J. A., Crowell M. D., De Petris G. (2012). Emergence of gastrointestinal basidiobolomycosis in the United States, with a review of worldwide cases. Clin. Infect. Dis. 54, 1685–1691. 10.1093/cid/cis250 [PubMed] [Cross Ref]
  • White T. J., Bruns T. D., Lee S. B., Taylor J. W. (1990). Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics, in PCR Protocols: A Guide to Methods and Applications, eds Innis M., Gelfand D., Sninsky J., White T., editors. (San Diego, CA: Academic Press; ), 315–322.
  • Wilson M. R., Naccache S. N., Samayoa E., Biagtan M., Bashir H., Yu G., et al. . (2014). Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N. Engl. J. Med. 370, 2408–2417. 10.1056/NEJMoa1401268 [PMC free article] [PubMed] [Cross Ref]

Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA